# $sgmo SGMO's ST-920 gene therapy for Fabry disease shows promising results, with positive clinical data and BLA submissions underway, positioning it as a potential leading treatment. ### About $sgmo SGMO is a biotechnology company focused on genomic medicine, particularly gene therapies. ### Top $sgmo Social Posts Top posts by engagements in the last [--] hours *Showing a maximum of [--] top social posts without a LunarCrush subscription.* "$SGMO Here we go. https://discord.gg/TEdTfmd98M https://discord.gg/TEdTfmd98M" [X Link](https://x.com/sukanto1639376/status/2018499655705714847) [@sukanto1639376](/creator/x/sukanto1639376) 2026-02-03T01:39Z [--] followers, [---] engagements "@thealphaledger Think it is a long term hold. Has to hit a homerun pls have a look at $CRMD $BCRX $TLX based on my DD (which is not as technical as you do) these companies are f'in undervalued - and catalyst rich. As goes for tomorrow or a near term a flip look at $SGMO and $QURE" [X Link](https://x.com/BAMBossie81/status/2018481814625755484) [@BAMBossie81](/creator/x/BAMBossie81) 2026-02-03T00:29Z [---] followers, [---] engagements "Hope $sgmo can monetize ST-920 somehow. No buyout as BP unlikely to pay a premium for a platform yet" [X Link](https://x.com/canoebrookbl/status/2018480266478846283) [@canoebrookbl](/creator/x/canoebrookbl) 2026-02-03T00:22Z [---] followers, [---] engagements "Day [--] @ WORLDSymposium [----] $SGMO already +60% this week into the eventST-920 Fabry gene therapy rolling BLA underway (filed Dec '25 full Q2 '26 push). Key platforms Thu/Fri: eGFR wins cardiac stability immunogenicity updates. Sanofi just flopped in Fabry Ph3game on #GeneTherapy $SGMO https://twitter.com/i/web/status/2018458928330240480 https://twitter.com/i/web/status/2018458928330240480" [X Link](https://x.com/yusufhameed/status/2018458928330240480) [@yusufhameed](/creator/x/yusufhameed) 2026-02-02T22:58Z [----] followers, [----] engagements Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
SGMO's ST-920 gene therapy for Fabry disease shows promising results, with positive clinical data and BLA submissions underway, positioning it as a potential leading treatment.
SGMO is a biotechnology company focused on genomic medicine, particularly gene therapies.
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"$SGMO Here we go. https://discord.gg/TEdTfmd98M https://discord.gg/TEdTfmd98M"
X Link @sukanto1639376 2026-02-03T01:39Z [--] followers, [---] engagements
"@thealphaledger Think it is a long term hold. Has to hit a homerun pls have a look at $CRMD $BCRX $TLX based on my DD (which is not as technical as you do) these companies are f'in undervalued - and catalyst rich. As goes for tomorrow or a near term a flip look at $SGMO and $QURE"
X Link @BAMBossie81 2026-02-03T00:29Z [---] followers, [---] engagements
"Hope $sgmo can monetize ST-920 somehow. No buyout as BP unlikely to pay a premium for a platform yet"
X Link @canoebrookbl 2026-02-03T00:22Z [---] followers, [---] engagements
"Day [--] @ WORLDSymposium [----] $SGMO already +60% this week into the eventST-920 Fabry gene therapy rolling BLA underway (filed Dec '25 full Q2 '26 push). Key platforms Thu/Fri: eGFR wins cardiac stability immunogenicity updates. Sanofi just flopped in Fabry Ph3game on #GeneTherapy $SGMO https://twitter.com/i/web/status/2018458928330240480 https://twitter.com/i/web/status/2018458928330240480"
X Link @yusufhameed 2026-02-02T22:58Z [----] followers, [----] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
/topic/$sgmo